Methylphenidate: Uses, Dosage & Side Effects

What Is Methylphenidate and What Is It Used For?

Methylphenidate is a central nervous system (CNS) stimulant that improves attention, concentration and impulse control by increasing dopamine and norepinephrine activity in underactive brain regions. It is approved for the treatment of ADHD in children aged 6 years and older as well as adults.

Methylphenidate belongs to a group of medicines known as centrally acting sympathomimetics. It is the most widely used medication for attention deficit hyperactivity disorder (ADHD) worldwide and has been available since the 1950s, giving clinicians decades of experience with its safety and efficacy profile. The World Health Organization (WHO) includes methylphenidate on its Model List of Essential Medicines, recognising it as one of the most effective and safe medicines needed in a health system.

The medication works by blocking the reuptake of the neurotransmitters dopamine and norepinephrine in the brain. In people with ADHD, certain brain regions responsible for attention, executive function and impulse control are underactive. By increasing the availability of these neurotransmitters, methylphenidate helps restore normal brain activity in these areas, leading to improvements in focus, organisational skills and behaviour.

Methylphenidate is always prescribed as part of a comprehensive treatment programme. Non-pharmacological interventions such as cognitive behavioural therapy (CBT), psychoeducation, behavioural strategies and educational accommodations should be tried first or used alongside medication. A specialist in ADHD – such as a psychiatrist, child and adolescent psychiatrist, or paediatrician with ADHD expertise – must initiate and supervise treatment.

Who can take methylphenidate?

Methylphenidate is approved for use in children aged 6 years and older, adolescents and adults who have been diagnosed with ADHD. A thorough clinical assessment must confirm the diagnosis before treatment begins. For adults who were not treated as children, the prescribing doctor will perform additional tests to verify that ADHD symptoms were present since childhood, as ADHD is a neurodevelopmental condition that begins in early life.

The medication should not be used in children under 6 years of age, as safety and efficacy have not been established in this age group. It is also not appropriate for treating normal childhood inattention or behavioural issues that do not meet the diagnostic criteria for ADHD.

About ADHD

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition characterised by persistent patterns of inattention, hyperactivity and impulsivity that interfere with daily functioning. ADHD affects approximately 5–7% of children and 2.5–4% of adults worldwide. Common symptoms include difficulty concentrating, forgetfulness, restlessness, excessive talking, difficulty completing tasks, impulsive decision-making and emotional instability. ADHD does not affect intelligence, and with appropriate treatment, people with ADHD can lead highly successful lives.

What Should You Know Before Taking Methylphenidate?

Before starting methylphenidate, your doctor will conduct a thorough medical and psychiatric assessment, including cardiovascular screening. The medication is contraindicated in patients with glaucoma, pheochromocytoma, hyperthyroidism, severe cardiovascular disease, or concurrent use of MAO inhibitors.

Methylphenidate is a powerful medication that requires careful medical oversight. Before prescribing it, your doctor will review your complete medical history, family history and current medications. This thorough assessment is essential to ensure the medication is safe and appropriate for you or your child. Below are the key contraindications, warnings and precautions you need to be aware of.

Contraindications – Do not take methylphenidate if you:

• Are allergic to methylphenidate hydrochloride or any of the other ingredients
• Have thyroid problems (hyperthyroidism)
• Have raised pressure in the eye (glaucoma)
• Have a tumour of the adrenal gland (pheochromocytoma)
• Have an eating disorder such as anorexia nervosa
• Have very high blood pressure or narrowing of blood vessels
• Have or have had heart problems such as heart attack, irregular heartbeat, heart failure, or congenital heart disease
• Have had cerebrovascular disease such as stroke, brain aneurysm or vasculitis
• Are taking or have taken a monoamine oxidase (MAO) inhibitor within the last 14 days
• Have certain psychiatric conditions including psychosis, schizophrenia, severe depression with suicidal thoughts, or mania

Warnings and Precautions

Tell your doctor before starting methylphenidate if you or your child:

• Have liver or kidney problems
• Have a history of seizures (epilepsy) or abnormal EEG
• Have ever misused or been dependent on alcohol, drugs or medications
• Have motor or vocal tics or a family history of Tourette syndrome
• Have high blood pressure
• Have any heart condition not listed in the contraindications above
• Have a mental health condition such as bipolar disorder, aggression, hallucinations, paranoia, anxiety or depression
• Have difficulty swallowing tablets

Your doctor will conduct a number of checks before starting treatment, including assessing your cardiovascular status, psychiatric history, family history of sudden unexplained death, and current emotional state. For adults who have not been treated previously, your doctor may refer you to a heart specialist for evaluation.

Cardiovascular Monitoring

Methylphenidate can increase blood pressure and heart rate. Before and during treatment, your doctor will regularly monitor your blood pressure and pulse. People with pre-existing hypertension, heart failure, recent heart attack or heart rhythm disturbances should generally not take this medication. If you experience chest pain, unexplained fainting, or shortness of breath during treatment, seek medical attention immediately.

Psychiatric Monitoring

In rare cases, methylphenidate may cause or worsen psychiatric symptoms including aggression, hallucinations, delusions, mania, or suicidal thoughts. Your doctor will monitor your mood, thoughts and behaviour during treatment. Report any unusual changes in mood, new or worsening aggressive behaviour, or thoughts of self-harm to your doctor immediately. People with a history of bipolar disorder are at particular risk of manic episodes when taking stimulant medications.

Pregnancy and Breastfeeding

Available data does not suggest an overall increased risk of birth defects when taking methylphenidate during pregnancy. However, a small increase in the risk of heart malformations cannot be ruled out when the medication is used during the first trimester. If you are pregnant, planning to become pregnant, or breastfeeding, discuss this with your doctor before starting or continuing treatment. Your doctor will weigh the potential benefits against the risks to make an informed decision.

There is limited evidence suggesting that methylphenidate may pass into breast milk. Your doctor will decide whether breastfeeding is appropriate during treatment. If you are sexually active, your doctor may discuss contraception with you.

Driving and Operating Machinery

Methylphenidate may cause dizziness, drowsiness, difficulty focusing, blurred vision or other central nervous system effects. If you experience any of these, do not drive, operate machinery or engage in potentially dangerous activities until the effects have resolved. You are responsible for assessing your own fitness to drive.

How Does Methylphenidate Interact with Other Drugs?

Methylphenidate has significant interactions with MAO inhibitors (contraindicated), antihypertensive drugs, anticoagulants, antiepileptics and some anaesthetics. Always inform your doctor and pharmacist about all medications you are taking, including over-the-counter products.

Drug interactions can alter how methylphenidate or other medications work, potentially reducing effectiveness or increasing the risk of side effects. It is essential to tell your doctor about all medications you are currently taking or have recently taken, including prescription drugs, over-the-counter medicines, herbal supplements and vitamins. Below is a summary of the most important known interactions.

Important Notes About Interactions

Extended-release (modified-release) capsules and tablets should not be taken with H2-receptor blockers, proton pump inhibitors (PPIs) or antacids that reduce stomach acid production. These medications can alter the pH of the stomach and affect the release mechanism, potentially causing the entire dose to be released too quickly. If you require acid-reducing medication, discuss alternative options with your doctor.

If you are scheduled for surgery, inform your surgeon and anaesthesiologist that you are taking methylphenidate. The medication should not be taken on the day of surgery if certain anaesthetic agents are to be used, as there is a risk of a sudden blood pressure increase during the procedure.

What Is the Correct Dosage of Methylphenidate?

The dosage of methylphenidate is individualised for each patient. Treatment typically starts at a low dose (5–10 mg daily for children, 10 mg daily for adults) and is gradually increased. The maximum daily dose is 60 mg for children and 80 mg (or 1 mg/kg body weight) for adults, depending on the formulation.

Methylphenidate dosing is always personalised. Your doctor will start with the lowest effective dose and gradually increase it based on your response and tolerability. The goal is to find the minimum dose that provides adequate symptom control with the fewest side effects. Never change your dose without consulting your doctor.

Children (aged 6 years and older)

Adults

How to Take Methylphenidate

Methylphenidate is taken by mouth (orally). The specific timing depends on the formulation:

• Immediate-release tablets: Usually taken 2–3 times daily, before or with meals
• Extended-release capsules (e.g. Medikinet): Children take once daily in the morning with breakfast; adults take with breakfast and lunch
• Extended-release tablets (e.g. Concerta): Once daily in the morning, with or without food

Extended-release capsules may be opened and the contents sprinkled on a small amount of applesauce or yoghurt and swallowed immediately. Do not crush, chew or store the contents for later use. Tablets should be swallowed whole with a glass of water.

Ongoing Monitoring

Your doctor will conduct regular check-ups during treatment, typically at least every six months. These reviews include:

• Measurement of blood pressure and heart rate
• Assessment of appetite and weight (and height in children)
• Evaluation of mood, behaviour and mental health
• Review of whether the medication is still needed

If treatment has continued for more than one year, your doctor may suggest a trial period without medication (a “drug holiday”) to reassess whether symptoms have improved sufficiently to continue without the drug. In children, this is often timed during a school holiday.

Missed Dose

If you forget a dose, take the next dose at the usual time. Do not take a double dose to make up for a missed one. If you regularly forget doses, talk to your doctor about strategies to help you remember.

Overdose

Stopping Treatment

Do not stop taking methylphenidate suddenly without your doctor’s guidance. If treatment is to be discontinued, your doctor will gradually reduce the dose over time to minimise the risk of rebound symptoms (worsening ADHD symptoms) or withdrawal effects such as depression. Always discuss any plans to stop treatment with your doctor first.

What Are the Side Effects of Methylphenidate?

The most common side effects of methylphenidate include decreased appetite, headache, insomnia and nervousness. Most side effects are mild and improve over time. Serious but rare side effects include cardiovascular events, psychiatric symptoms and priapism. Report any unusual symptoms to your doctor.

Like all medicines, methylphenidate can cause side effects, although not everyone experiences them. Many side effects are dose-related and may improve as your body adjusts to the medication or if the dose is reduced. The side effects are categorised below by how frequently they occur.

Priapism – A Specific Warning for Males

During treatment, boys, adolescents and men may experience prolonged, potentially painful erections (priapism). This can occur at any time and is a medical emergency. If an erection lasts for more than 2 hours, especially if painful, seek immediate medical attention. Untreated priapism can cause permanent damage.

Effects on Growth in Children

Long-term use of methylphenidate (over one year) may lead to slower growth in some children. Fewer than 1 in 10 children are affected. Your doctor will carefully monitor your child’s height and weight throughout treatment. If growth is not progressing as expected, the doctor may temporarily pause treatment. Most studies indicate that final adult height is not significantly affected in the long term.

How Should You Store Methylphenidate?

Store methylphenidate at or below 30°C in the original packaging, away from moisture. Keep out of sight and reach of children. As a controlled substance, secure storage is particularly important to prevent misuse.

Proper storage of methylphenidate is essential both for maintaining the medication’s effectiveness and for safety, given that it is a controlled substance. Follow these guidelines:

• Temperature: Store at or below 30°C (86°F). Do not freeze.
• Moisture: Keep in the original blister packaging or container to protect from moisture.
• Light: Store away from direct sunlight.
• Security: Keep the medication in a secure location out of sight and reach of children and others, to prevent accidental ingestion or intentional misuse.
• Expiry: Do not use after the expiry date printed on the packaging. The expiry date refers to the last day of that month.
• Disposal: Do not dispose of unused medication in household waste or down the drain. Return unused tablets or capsules to your pharmacy for safe disposal to protect the environment.

What Does Methylphenidate Contain?

The active ingredient is methylphenidate hydrochloride. Inactive ingredients vary by brand and formulation but typically include lactose, starch, magnesium stearate, cellulose derivatives and coating agents. Check your specific product's packaging for the complete list of ingredients.

The active substance in all methylphenidate products is methylphenidate hydrochloride. The amount of active substance corresponds to slightly less methylphenidate base (for example, 10 mg methylphenidate hydrochloride corresponds to approximately 8.65 mg methylphenidate).

Inactive ingredients (excipients) vary depending on the manufacturer and formulation. Common excipients found in methylphenidate products include:

• Tablet core: Lactose monohydrate, maize starch, pregelatinised starch, magnesium stearate, talc
• Modified-release capsules: Sugar spheres (sucrose and maize starch), methacrylic acid copolymer, talc, triethyl citrate, poly(vinyl alcohol)
• Capsule shell: Gelatin, titanium dioxide (E171), various colourants depending on strength
• Extended-release tablets (OROS): Cellulose acetate, hypromellose, phosphoric acid, poloxamer, polyethylene oxide, povidone, sodium chloride, stearic acid

If you have lactose intolerance, sucrose intolerance or fructose intolerance, inform your doctor before starting treatment, as some formulations contain these sugars. Most methylphenidate products contain less than 1 mmol (23 mg) of sodium per dose and are considered essentially sodium-free.

Always read the package leaflet that comes with your specific medication for the complete list of ingredients. If you are allergic to any food colouring agents (such as erythrosine E127 or indigo carmine E132), check the ingredient list carefully, as these may be present in certain capsule formulations.

Frequently Asked Questions About Methylphenidate